^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    xentuzumab (BI-836845)

    i
    Other names: BI-836845, BI836845, BI 836845
    Company:
    Boehringer Ingelheim, Novartis
    Drug class:
    IGF-2 inhibitor, IGF1 inhibitor